Hans-Juergen Woerle

Hans-Juergen Woerle serves as the Chief Scientific and Medical Officer and Head of Clinical Development at Nestlé Health Science since October 2017, overseeing global clinical development across various therapeutic areas. Additionally, Hans-Juergen Woerle is a Board Member at Cerecin and Enterome since November 2020. Previously, at Boehringer Ingelheim from August 2007 to September 2017, responsibilities included Vice President of Therapeutic Area Metabolism, leading clinical development plans for metabolic diseases and executing major cardiovascular outcome trials, as well as serving as Associate Therapeutic Area Head. Academic training includes a Senior Fellowship in Research at the University of Munich focused on endocrinology and gastroenterology, and a Research Fellowship at the University of Rochester specializing in glucose and lipid physiology. Hans-Juergen Woerle earned an MD at Ludwig-Maximilians-Universität München.